FTC’s fines push Celltrion shares down

Published: 2013-04-11 06:57:00

Updated: 2013-04-11 06:57:00

Korea’s leading biopharmaceutical company Celltrion Inc., an affiliated company of Celltrion Holdings, took a direct hit from growing concern after the antitrust regulator levied Celltrion Holdings fines of 270 million won for breaching the law on holding firms that own subsidiaries on Tuesday.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK